Skip to main content
Premium Trial:

Request an Annual Quote

Christopher Rieder, Christopher Kiritsy, Mark McGovern, Fred Sexton, Inyoul Lee

Premium

Kos Pharmaceuticals of Miami has promoted Christopher Rieder to the newly created position of vice president of information technology. He will be responsible for overseeing the management information systems initiatives at the company. Prior to joining Kos in 1996, Rieder served as manager and associate director of information technology at North American Vaccine and BRI International.

Rieder is among four recent promotions at Kos: Christopher Kiritsy has been named senior vice president and CFO, Mark McGovern has been appointed as senior vice president and chief medical officer, and Fred Sexton has been tapped as senior vice president of technical operations and product development.

 

Inyoul Lee, a scientist at the Institute for Systems Biology in Seattle, has joined the scientific advisory board of Genops Bioinformatics, based in Vancouver, BC, Canada. Lee’s research currently focuses on immunology and prion biology.

Lee joins David Baillie of Simon Fraser University, Ian Dunham of the Wellcome Trust Sanger Institute, and Sunyoung Kim of Pangenomics on the company’s scientific advisory board.

Filed under

The Scan

Researchers Compare WGS, Exome Sequencing-Based Mendelian Disease Diagnosis

Investigators find a diagnostic edge for whole-genome sequencing, while highlighting the cost advantages and improving diagnostic rate of exome sequencing in EJHG.

Researchers Retrace Key Mutations in Reassorted H1N1 Swine Flu Virus With Avian-Like Features

Mutations in the acidic polymerase-coding gene boost the pathogenicity and transmissibility of Eurasian avian-like H1N1 swine influenza viruses, a PNAS paper finds.

Genome Sequences Reveal Evolutionary History of South America's Canids

An analysis in PNAS of South American canid species' genomes offers a look at their evolutionary history, as well as their relationships and adaptations.

Lung Cancer Response to Checkpoint Inhibitors Reflected in Circulating Tumor DNA

In non-small cell lung cancer patients, researchers find in JCO Precision Oncology that survival benefits after immune checkpoint blockade coincide with a dip in ctDNA levels.